Dysregulation of DA signaling (ascribable to either DAT1 polymorphisms or hyper/hypomethylation of DAT1 promoter) is also likely to be involved in eating disorders (EDs), including bulimia nervosa and binge eating disorder [11,12]. Here, SLC6A3 is linked to Ehlers-Danlos syndrome.